Symrise invests in Synergio
Symrise has made an unspecified investment to take a minority stake in Israeli biotech Synergio, with the option of owning a majority in future. Financial terms are not being disclosed.
Based in Jerusalem, Synergio specialises in developing natural antimicrobial combinations from plants for product protection, using a data-driven, biochemistry-based, computational platform. Symrise is already a major player in this field within the personal care sector and sees growth opportunities in working together with Synergio.